{"organizations": ["Symphony Icon Holdings LLC", "Addition of Four New Pharma Members", "Construction of Lifesaving Firefighter Academy", "Pfizer, Inc.", "Hepatitis C Therapeutics Market", "Inc.", "Vitatech Nutritional Sciences, Inc", "LLC", "VA", "Garden Media Group", "University of North Carolina", "Vitatech Nutritional Sciences, Inc.", "CT & NY BUSINESSES", "NIH", "Bard IVC Filters Products Liability Litigation", "HealthDay News", "Oramed Pharmaceuticals Inc.", "Lexicon Pharmaceuticals Announces Reacquisition of All Rights to Symphony Icon Programs Hepatitis C Therapeutics Market", "JPML Approves Arizona Consolidation", "T.E.N."], "uuid": "3ec5f2ffb954d5abbc9b3e56ffb4b1dfafbd13f5", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.bio-medicine.org", "main_image": "", "site_section": "http://www.bio-medicine.org/inc/biomed/medicine-technology.asp", "section_title": "Latest Medical Technology from Bio-Medicine.Org", "url": "http://www.bio-medicine.org/medicine-technology-1/VolitionRx-Demonstrates-NuQ-28R-29-Blood-Test-Detects-81-25-of-Colorectal-Cancers-and-67-25-of-High-Risk-Adenomas-in-Large-Double-Blinded-Clinical-Tri-48154-1/", "country": "US", "title": "VolitionRx Demonstrates NuQ(R) Blood Test Detects 81% of Colorectal Cancers and 67% of High Risk Adenomas in Large Double Blinded Clinical Trial", "performance_score": 0, "site": "bio-medicine.org", "participants_count": 0, "title_full": "VolitionRx Demonstrates NuQ(R) Blood Test Detects 81% of Colorectal Cancers and 67% of High Risk Adenomas in Large Double Blinded Clinical Trial", "spam_score": 0.0, "site_type": "news", "published": "2015-09-09T15:52:00.000+03:00", "replies_count": 0, "uuid": "3ec5f2ffb954d5abbc9b3e56ffb4b1dfafbd13f5"}, "author": "", "url": "http://www.bio-medicine.org/medicine-technology-1/VolitionRx-Demonstrates-NuQ-28R-29-Blood-Test-Detects-81-25-of-Colorectal-Cancers-and-67-25-of-High-Risk-Adenomas-in-Large-Double-Blinded-Clinical-Tri-48154-1/", "ord_in_thread": 0, "title": "VolitionRx Demonstrates NuQ(R) Blood Test Detects 81% of Colorectal Cancers and 67% of High Risk Adenomas in Large Double Blinded Clinical Trial", "locations": ["United States", "Omaha", "Taiwan", "SHANGHAI", "HAITI", "Port Au Prince", "Kingdomway", "Chapel Hill", "USA", "New York", "Alexandria", "Bridgeport", "Nebraska"], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": ["Bard", "Louis", "McCarthy", "Lauren Hale", "Marci McCarthy"], "text": " 9/9/2015)... 2015 Oramed Pharmaceuticals Inc. (NASDAQ: ... company focused on the development of oral drug delivery ... enrolled in the Company,s Phase IIb study of its ... of the 180 patients expected to be recruited for ... type 2 diabetes was initiated on June 30 th   SHANGHAI , Sept. 9, 2015 /PRNewswire/ ... four members from the pharmaceutical industry: Pfizer, Inc., H. ... GPCR Consortium originally planned for eight members; however, the ... first year. The GPCR Consortium is an ... institutes in the United States   , Sept. 9, 2015 Vitatech Nutritional Sciences, Inc. ... business to Kingdomway, USA , LLC. ... dietary supplements founded over 60 years ago in ... USA , LLC, is a wholly-owned subsidiary of ... commonly-used raw materials. The new company will be named ... [ 0 ] Oramed Completes Randomization of Over 50% of Patients in Phase IIb Oral Insulin Study [ 0 ] GPCR Consortium Exceeds Goal with Addition of Four New Pharma Members [ 0 ] Vitatech Nutritional Sciences, Inc. Announces the Sale Of Its Nutritional Products Manufacturing Business ... Lexicon Pharmaceuticals, Inc. (Nasdaq: ... and developing breakthrough treatments for human disease, today announced that ... development financing collaboration with Symphony Icon Holdings LLC and acquired ... rights to LX1031, LX1032, LX1033 and the other drug programs ... ... announces that a new market research report is available in its catalogue: , ... Hepatitis C Therapeutics Market - Taiwan , ... http://www.reportlinker.com/p0236386/Hepatitis-C-Therapeutics-Market---Taiwan.html , , ... research service aims to provide an update on the epidemiology of Hepatitis C, including the ... Lexicon Pharmaceuticals Announces Reacquisition of All Rights to Symphony Icon Programs Hepatitis C Therapeutics Market - Taiwan (Date:9/9/2015)...   A sorely-needed firefighters ... and New York tri-state area businesses known as Haiti Works! Led by Bridgeport Reverend ... organization has already sent the community of Petion-ville, outside of Port Au Prince,   ... of the TiE Top Entrepreneurs for 2015. The recognition honest top metro Atlanta-area ... companies that show growth, profitability, and sustainability. , McCarthy is responsible for   Louis, MO (PRWEB) , ... September 09, 2015 ... ... that national IVC filter lawsuits filed against Bard would be consolidated as multidistrict ... known as Bard IVC Filters Products Liability Litigation, initially provides for the transfer   PA   ... with Nature identifies eight consumer trends that will shake up the garden and ... has transformed into a connected lifestyle in 2016. The rising millennial generation is constantly   ,   Please join us for the 3rd Annual ... Lake, located at the 156th and “F” Street Entrance at Shelter 5 in Omaha, Nebraska. ... 3rd year, the 3rd Annual A Sharp Race Towards Brain Aneurysm Awareness will consist of ... [ 0 ] CT & NY BUSINESSES STEP UP FOR HAITI; September 9th Fundraiser For Construction of Lifesaving Firefighter Academy [ 0 ] T.E.N. CEO & President Marci McCarthy Selected as 2015 TiE Top Entrepreneur [ 0 ] Bard IVC Lawsuit News: JPML Approves Arizona Consolidation [ 0 ] Garden Media Group Releases 2016 Garden Trends Report: “Syncing with Nature” [ 0 ] Register Now for 3rd Annual Brain Aneurysm Awareness Event in Honor of Local Survivor and Receive Complimentary T-Shirt ... HealthDay Reporter , MONDAY, July 18 (HealthDay News) -- ... statins might raise the risk of cancer. Among approximately ... electronic database, researchers report there was no significant difference in ... didn,t. After an average of five years of follow-up ... ... HealthDay Reporter , MONDAY, July 18 (HealthDay News) -- Allowing ... behavioral or learning problems down the road, new research suggests. ... during the first year of life, due to increased risk ... Lauren Hale, an associate professor of preventive medicine in the ... ... 18 (HealthDay News) -- Genetically engineered human cardiac stem cells ... new study. And, the researchers revealed, 10 weeks ... in these mice doubled that of control animals. They also ... \"This study brings us one step closer to a clinical ... ... HealthDay Reporter , MONDAY, July 18 (HealthDay ... blood pressure modestly among hypertensive patients, a small, new ... refined carbohydrates -- such as white bread and white ... protein \"might be an important component of nutrition intervention ... ... the University of North Carolina at Chapel Hill schools ... million federal grant to develop and test a new ... HIV to uninfected individuals. This remains the most common ... award is entitled Next Generation Pre-Exposure Prophylaxis, or PrEP. ... ... Alexandria, VA, USA The microblogging service Twitter is ... concerns and could afford health care professionals new ways ... user-generated online content via social networking Web sites such ... revolution in communication and information sharing. In a study ... Statins Don't Seem to Raise Cancer Risk Sharing Bed With Toddler Won't Harm Development: Study Human Stem Cells Used to Fix Damaged Mouse Heart Small Study Suggests Milk, Soy Proteins Lower Blood Pressure Modestly UNC receives NIH grant to develop and test new drugs to block HIV infection IADR/AADR publish study on use of Twitter for public health surveillance of dental pain ... 70% alcohol and 10% povidone iodine ... forming a barrier on the skin. ... for the povidone iodine, giving persistent ... with catheter related infections for up ... ... in easy open, single-use foil-laminated pouches. Each ... the correct amount of solution. Each package ... product for the patient. Iodine Tincture, 2% ... of ethyl alcohol and iodine creating a ... ... are packaged in single-use foil-laminated ... is saturated with precisely the ... package is terminally sterilized, ensuring ... the patient. Swabstick provides excellent ... ... Povidone Iodine 'Prep' solutions ... and mucous membrane preparation ... All Povidone Iodine 'Scrub' ... with surfactants. Each is ...", "external_links": [], "published": "2015-09-09T15:52:00.000+03:00", "crawled": "2015-09-09T16:03:56.700+03:00", "highlightTitle": ""}